Scientists mapped 11,692 gene knockdowns in stem cells — all in one atlas
Genome editing had a busy week — from a stem cell atlas covering nearly 12,000 genes to lipid nanoparticles sneaking CRISPR past the blood-brain barrier.
The throughline: researchers keep finding new ways to ask 'what does this gene actually do?' and actually get answers.
🧬 The Stem Cell Wiring Diagram Is Here
- Researchers built a genome-scale perturbation atlas in human induced pluripotent stem cells, knocking down 11,692 genes one by one and reading out the effects across more than 2.5 million single cells — the most comprehensive map of the pluripotent state to date.
- The atlas isn't just a lookup table. Correlations between perturbed genes reliably reconstructed known protein complexes, meaning the data has enough resolution to surface real biology, not noise. Two previously undercharacterized regulators — metabolic factor ZBTB41 and pluripotency regulator RNF7 — were validated through follow-up experiments.
- The team also used the atlas to run a genome-scale screen for RNA-editing regulators, uncovering DBR1 as a potent modulator — a finding they mechanistically confirmed.
Why it matters: A publicly accessible resource that links genotype to transcriptional phenotype at this scale gives the field a shortcut: before running a new experiment, check whether the answer is already in the atlas.
Key Findings
🍄 Prime Editing Now Works in Fungi — and Found 8 New Molecules
- Researchers developed fPE7max, a prime editing platform optimized for filamentous fungi, achieving average editing efficiency near 90% across multiple species and genomic sites.
- By editing upstream regulatory sequences in a key fungal gene, they activated dormant biosynthetic pathways — metabolomic profiling turned up 18 metabolites, including 8 previously unreported structures, 3 of which showed cytotoxic activity.
🫁 A Splicing Mutation in Lung Cancer Is Actually a Rescue Act
- A specific KRAS mutation (G12S) causes the cell to skip a critical exon, producing a nonfunctional KRAS protein — a self-defeating oncogenic event. But a co-occurring splicing factor mutation (U2AF1-S34F) reverses that exon skipping and restores KRAS function, explaining why these two mutations are found together in patient tumors far more often than chance.
- A second pairing — KRAS Q61R and U2AF1 I24T — follows the same logic, confirmed experimentally.
🧠 Biodegradable Nanoparticles Deliver Gene Editing Deep Into the Brain
- A 200-member library of biodegradable ionizable lipids was screened in live mice via intrathecal injection (into the spinal canal, bypassing the blood-brain barrier). The lead candidate, P3B, drove widespread gene editing in neurons and astrocytes across multiple brain regions.
- Compared to a clinical benchmark lipid, P3B showed substantially higher editing efficiency, attenuated inflammatory responses, and a tolerability profile compatible with repeat dosing.
🦠 Engineered Salmonella Made Less Immunosuppressive With CRISPRi
- Salmonella used as a cancer immunotherapy normally injects proteins that suppress the host immune response after invading cells. Researchers used CRISPRi to dial down two of those effectors, shifting the downstream signaling: less immunosuppressive IL-10, more pro-inflammatory TNF-α, and increased cancer cell death.
- The study is the first demonstration that CRISPRi modulation of bacterial effectors can reshape mammalian cell physiology during bacterial therapy.
🌿 Transgene-Free Crop Editing Is Closing In on Regulatory-Friendly Precision
- A review of transgene-free genome editing in plants maps the current toolkit: direct delivery of ribonucleoprotein complexes, mRNA-based delivery, base editors, and prime editing — all approaches that modify the genome without leaving foreign DNA behind.
- The appeal is regulatory as much as scientific: edits made without stable foreign DNA integration are increasingly treated as non-GMO in several jurisdictions, opening a faster path for crop improvement.
🍋 The Gene That Makes Kumquats Sour (or Not) Has Been Identified
- By crossing a low-acid kumquat with a high-acid variety and mapping the offspring, researchers pinpointed a GRAS transcription factor — ChSCL9 — as a key regulator of citric acid accumulation. CRISPR-Cas9 knockout and overexpression experiments confirmed it directly represses two genes responsible for acidifying the fruit's vacuoles.
- The finding identifies an upstream regulator of fruit acidity and gives breeders a concrete molecular target for flavor engineering in citrus.
Implications
From stem cell atlases to brain-targeted nanoparticles, the week's work keeps compressing the gap between 'what does this gene do' and a usable answer. The open tension: delivery and scale are converging fast, but whether editing efficiency in animal models translates to human tissue complexity remains the field's stubbornest unsolved problem.
Studies in this issue
Primary sources used for this newsletter.
- A large-scale map of gene activity control in human stem cellsmain storyNature biotechnology2026-07-01PMID 42386990
- Genome editing in plants without using foreign geneskey findingaBIOTECH2026-06-30PMID 42375648
- ChSCL9 reduces citric acid buildup by blocking the PH4-PH5 system in kumquatkey findingPlant physiology2026-06-30PMID 42378656
- Using prime editing for accurate gene changes and controlling fungal metabolismkey findingNature biotechnology2026-06-30PMID 42380278
- U2AF1 mutations may reverse harmful gene skipping caused by KRAS mutationskey findingNature genetics2026-07-01PMID 42386932
- Using CRISPRi to Reduce Salmonella Proteins That Influence the Immune Response to Bacterial Treatmentskey findingACS synthetic biology2026-06-30PMID 42378072
- Biodegradable fat-based particles for editing genes in the brain through spinal fluid injectionkey findingMaterials today (Kidlington, England)2026-07-02PMID 42388231
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.